The U.S. Meals and Drug Administration (FDA) has accepted PD-L1 IHC 22C3 pharmDx, Code SK006, as a companion diagnostic to assist establish sufferers with epithelial...
Minimal residual illness, or MRD, testing might have the potential to supply peace of thoughts to survivors of breast most cancers, as a survivor and...
The U.S. Meals and Drug Administration (FDA) has granted breakthrough remedy designation to an investigational CAR-T cell remedy, soficabtagene geleucel (Sofi-cel), for...
Sufferers with Waldenström Non-Hodgkin lymphoma within the U.S. achieved sturdy full responses of as much as 15 months utilizing a chemotherapy-free CD19...
Throughout the 2026 ASCO Gastrointestinal (GI) Cancers Symposium, CURE was stay on website, the place we spoke immediately with conferencegoers, oncologists and...
When San Francisco-based surgeon Dr. Anne Peled determined to bear a sensation-preserving mastectomy following her second analysis of breast most cancers, she...
New analysis from the worldwide CATNON trial exhibits that sufferers with newly recognized 1p/19q non-co-deleted anaplastic astrocytomas who obtained radiotherapy adopted by...
